Drawing for INFINIUM

USPTO serial 86392986

INFINIUM

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
Examiner
RITTNER, HANNO I
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INFINIUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joe Foye

JOE FOYE MOHAWK160 S INDUSTRIAL BLVDCALHOUN, GA 30701-3030UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
019Vinyl tilesABANDONED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 20, 2015MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Apr 20, 2015ABN5ABANDONMENT - AFTER PUBLICATION
Apr 16, 2015EXARTEAS EXPRESS ABANDONMENT RECEIVED
Jan 28, 2015ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Dec 30, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 30, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 10, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 20, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2014DOCKASSIGNED TO EXAMINER
Sep 19, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2014NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance